Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOWAR: Low Titer Whole Blood for Prehospital Resuscitation
NCT04684719Phase 3Completed
- Start
- Apr 2022
- Primary completion
- Jul 2025
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of low-titer group O whole blood in hemorrhagic shock and traumatic injury. Primary endpoint: 30-day Mortality. Started Apr 2022; status: completed.
02
Drugs
low-titer group O whole blood
03
Conditions
hemorrhagic shocktraumatic injury
Beyond the preview
Go deeper on NCT04684719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684719.